Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 5
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Nobivac DHPPi - V/NRP/93/0047 Intervet International B.V., Nīderlande QI07AD04 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live Canine parainfluenza virus (CPi) strain Cornell,Live Canine adenovirus type 2 (CAV2), strain Manhattan LPV3,Live Canine distemper virus (CDV) strain Onderstepoort,Live Canine parvovirus (CPV), strain 154
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande;Intervet International B.V., Nīderlande
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0047-01 5 Stikla flakons; satur liofilizētu granulu, 1 deva -
V/NRP/93/0047-02 10 Stikla flakons; satur liofilizētu granulu, 1 deva -
V/NRP/93/0047-03 25 Stikla flakons; satur liofilizētu granulu, 1 deva -
V/NRP/93/0047-04 50 Stikla flakons; satur liofilizētu granulu, 1 deva -
Porcilis M Hyo ID Once - V/DCP/11/0071 Intervet International B.V., Nīderlande QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Mycoplasma hyopneumoniae, strain 11
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 28-Apr-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Feb-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0071-04 1 Stikla flakons, 50 deva -
V/DCP/11/0071-05 5 Stikla flakons, 50 deva -
V/DCP/11/0071-06 10 Stikla flakons, 50 deva -
V/DCP/11/0071-07 1 Stikla flakons, 100 deva -
V/DCP/11/0071-08 5 Stikla flakons, 100 deva -
V/DCP/11/0071-09 10 Stikla flakons, 100 deva -
V/DCP/11/0071-10 1 Polietilēna flakons, 100 deva -
V/DCP/11/0071-11 5 Polietilēna flakons, 100 deva -
V/DCP/11/0071-12 10 Polietilēna flakons, 100 deva -
Nobilis IB Ma5 - V/NRP/00/1185 Intervet International BV, Nīderlande QI01AA03 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 09-Mar-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/00/1185-01 10 Flakons, 1000 deva -
V/NRP/00/1185-02 10 Flakons, 2500 deva -
V/NRP/00/1185-03 10 Flakons, 5000 deva -
V/NRP/00/1185-04 10 Flakons, 10000 deva -
V/NRP/00/1185-07 10 Kausiņš, 10000 deva -
V/NRP/00/1185-08 10 Kausiņš, 5000 deva -
V/NRP/00/1185-09 10 Kausiņš, 1000 deva -
V/NRP/00/1185-10 10 Kausiņš, 2500 deva -
V/NRP/00/1185-11 12 Kausiņš, 1000 deva -
V/NRP/00/1185-12 12 Kausiņš, 2500 deva -
V/NRP/00/1185-13 12 Kausiņš, 5000 deva -
V/NRP/00/1185-14 12 Kausiņš, 10000 deva -
Nobilis Ma5 + Clone 30 - V/NRP/95/0165 Intervet International B.V., Nīderlande QI01AA10 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live, Live Newcastle Disease virus, strain Clone 30
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0165-02 10 Flakons, 1000 deva -
V/NRP/95/0165-03 10 Flakons, 2500 deva -
V/NRP/95/0165-04 6 Kausiņš, 1000 deva -
V/NRP/95/0165-05 6 Kausiņš, 2500 deva -
V/NRP/95/0165-06 6 Kausiņš, 5000 deva -
V/NRP/95/0165-07 6 Kausiņš, 10000 deva -
V/NRP/95/0165-08 12 Kausiņš, 1000 deva -
V/NRP/95/0165-09 12 Kausiņš, 2500 deva -
V/NRP/95/0165-10 12 Kausiņš, 5000 deva -
V/NRP/95/0165-11 12 Kausiņš, 10000 deva -
Nobilis ND Clone 30 - V/NRP/95/0175 Intervet International B.V., Nīderlande QI01AD06 turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Live Newcastle Disease virus, strain Clone 30
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0175-01 10 Flakons, 1000 deva -
V/NRP/95/0175-02 10 Flakons, 2500 deva -
V/NRP/95/0175-03 10 Flakons, 5000 deva -
V/NRP/95/0175-04 12 Kausiņš, 1000 deva -
V/NRP/95/0175-05 12 Kausiņš, 2500 deva -
V/NRP/95/0175-06 6 Kausiņš, 10000 deva -
V/NRP/95/0175-07 12 Kausiņš, 5000 deva -
Lincomycin-spectinomycin - V/NRP/97/0543 Alfasan Nederland BV, Nīderlande QJ01FF52 pigs; sheep; goats; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lincomycin hydrohloride,Spectinomycin hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan International B.V., Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 13022026LI (13-Feb-2026)
Labelling text: [DOC] 13022026M (13-Feb-2026)
Summary of product characteristics: [DOC] 13022026ZA (13-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0543-01 1 Flakons, 100 ml -
V/NRP/97/0543-02 1 Flakons, 50 ml -
V/NRP/97/0543-03 1 Flakons, 250 ml -
Oxytetracycline 10% 100 mg/ml V/NRP/97/0603 Alfasan Nederland BV, Nīderlande QJ01AA06 cattle; pigs; sheep; goats; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Oxytetracycline hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan International B.V., Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 13022026LI (13-Feb-2026)
Labelling text: [DOCX] 13022026M (13-Feb-2026)
Summary of product characteristics: [DOCX] 13022026ZA (13-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0603-04 100 mg/ml 1 Stikla (tumša) flakons, 100 ml -
V/NRP/97/0603-07 100 mg/ml 12 Stikla (tumša) flakons, 100 ml -
Ampicillin 20% 200 mg/ml V/NRP/05/1637 Alfasan Nederland BV, Nīderlande QJ01CA01 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ampicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan International B.V., Nīderlande
Date of authorisation/renewal: 30-Dec-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 13022026LI (13-Feb-2026)
Labelling text: [DOC] 13022026M (13-Feb-2026)
Summary of product characteristics: [DOC] 13022026ZA (13-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/05/1637-01 200 mg/ml 1 Stikla flakons, 100 ml -
Alfasan Eye Ointment - V/NRP/97/0541 Alfasan Nederland BV, Nīderlande QS01AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: eye ointment
International name (active substance): Chloramphenicol,A vitamin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan International B.V., Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 13022026LI (13-Feb-2026)
Labelling text: [DOCX] 13022026M (13-Feb-2026)
Summary of product characteristics: [DOCX] 13022026ZA (13-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0541-01 12 Tūbiņa, 4 g -
Betamox LA 150 mg/ml V/NRP/96/0446 Norbrook Laboratories (Ireland) Limited, Īrija QJ01CA04 cattle; pigs; sheep; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 16-Apr-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 19122022LI (16-Apr-2026)
Labelling text: [PDF] 201120M (16-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0446-01 150 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0446-02 150 mg/ml 1 Stikla flakons, 100 ml -
V/NRP/96/0446-03 150 mg/ml 1 Polietilēna flakons, 50 ml -
V/NRP/96/0446-04 150 mg/ml 1 Polietilēna flakons, 100 ml -
V/NRP/96/0446-05 150 mg/ml 1 Polietilēna flakons, 250 ml -
V/NRP/96/0446-06 150 mg/ml 1 Polietilēna flakons, 500 ml -
V/NRP/96/0446-07 150 mg/ml 1 Stikla flakons, 250 ml -
KETOPROCEN 150 mg/ml V/DCP/26/0007 Cenavisa S.L, Spānija QM01AE03 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 04-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0007-01 1 Stikla flakons, 100 ml -
V/DCP/26/0007-02 1 Stikla flakons, 250 ml -
V/DCP/26/0007-03 1 Polipropilēna flakons, 100 ml -
V/DCP/26/0007-04 1 Polipropilēna flakons, 250 ml -
Norocillin 300 mg/ml V/NRP/98/0806 Norbrook Laboratories (Ireland) Limited, Īrija QJ01CE09 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0806-01 300 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/98/0806-02 300 mg/ml 1 Stikla flakons, 100 ml -
Longosona 1 mg/ml V/NRP/99/0934 Industrial Veterinaria, S.A. - Invesa, Spānija QH02AB02 cattle; pigs; sheep; horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Dexamethasone isonicotinate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A. - Invesa, Spānija
Date of authorisation/renewal: 30-Apr-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 71-230409LI (30-Apr-2009)
Labelling text: [DOC] 23042009M (30-Apr-2009)
Summary of product characteristics: [PDF] 71-230409ZA (30-Apr-2009)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0934-01 1 mg/ml 1 Stikla flakons, 10 ml -
V/NRP/99/0934-02 1 mg/ml 1 Stikla flakons, 50 ml -
Levamisol 100 100 mg/ml V/NRP/97/0634 Industrial Veterinaria, S.A., Spānija QP52AE01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Levamisol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A. - Invesa, Spānija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 230210LI (26-Feb-2010)
Labelling text: [DOC] 26022010 (26-Feb-2010)
Summary of product characteristics: [PDF] 230210ZA (26-Feb-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0634-03 100 mg/ml 1 Flakons, 100 ml -
V/NRP/97/0634-04 100 mg/ml 1 Flakons, 250 ml -
Hierrodexina - V/NRP/96/0447 Industrial Veterinaria, S.A., Spānija QB03AE04 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cobalt chloride, Cyanocobalamin, Ferric polysaccharide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A. - Invesa, Spānija
Date of authorisation/renewal: 21-May-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 230210LI (26-Feb-2010)
Labelling text: [DOC] 230210M (26-Feb-2010)
Summary of product characteristics: [PDF] 230210ZA (26-Feb-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0447-01 1 Flakons, 50 ml -
V/NRP/96/0447-02 1 Flakons, 100 ml -
Jodofoam Endofoam A.U.V. - V/NRP/08/1595 Fortevit Kft., Ungārija QG51AD30 cattle Vairāk

Medicinal product information

Pharmaceutical form: intrauterine foam
International name (active substance): Iodine,Potassium iodide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pernix Pharma Pharmaceutical Manufacturing Ltd., Ungārija
Date of authorisation/renewal: 27-Feb-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1595-01 0,2 g/0,4 g 10 Alumīnija baloniņš, 45,2 g -
Robexera 6 mg V/DCP/25/0076 KRKA, d.d., Novo mesto, Slovēnija QM01AH91 cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija;KRKA-FARMA d.o.o., Horvātija
Date of authorisation/renewal: 12-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0076-01 1 OPA/Al/PVH-Al blisteris, 6 tablete -
V/DCP/25/0076-02 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/25/0076-03 3 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/25/0076-04 6 OPA/Al/PVH-Al blisteris, 10 tablete -
Kenocidin Spray and Dip 5 mg/ml V/MRP/12/0019 Cid Lines NV, Beļģija QD08AC02 dairy cows Vairāk

Medicinal product information

Pharmaceutical form: teat dip / teat spray solution
International name (active substance): Chlorhexidine digluconate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Cid Lines NV, Beļģija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300115LI (03-Feb-2015)
Labelling text: [DOCX] 26112021M (26-Nov-2021)
Summary of product characteristics: [DOCX] 26112021ZA (26-Nov-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0019-01 5 mg/g 1 Polietilēna konteiners, 1 l -
V/MRP/12/0019-02 5 mg/g 1 Polietilēna konteiners, 5 l -
V/MRP/12/0019-03 5 mg/g 1 Polietilēna konteiners, 10 l -
V/MRP/12/0019-04 5 mg/g 1 Polietilēna konteiners, 20 l -
V/MRP/12/0019-05 5 mg/g 1 Polietilēna konteiners, 25 l [JPG]
V/MRP/12/0019-06 5 mg/g 1 Polietilēna konteiners, 60 l -
V/MRP/12/0019-07 5 mg/g 1 Polietilēna konteiners, 200 l -
Virbactan 150 mg V/MRP/05/1640 Virbac S.A., Francija QJ51DE90 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary ointment
International name (active substance): Cefquinome (as cefquinome sulfate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija;Intervet International GmbH, Vācija
Date of authorisation/renewal: 09-Jul-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 171221LI (11-Oct-2023)
Labelling text: [PDF] 171221M (11-Oct-2023)
Summary of product characteristics: [DOCX] 171221ZA (11-Oct-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/05/1640-01 150 mg 4 Pilnšļirce, 1 deva [PDF]
V/MRP/05/1640-02 150 mg 20 Pilnšļirce, 1 deva [PDF]
V/MRP/05/1640-03 150 mg 60 Pilnšļirce, 1 deva [PDF]
V/MRP/05/1640-04 150 mg 24 Pilnšļirce, 1 deva [JPG] [JPG] [JPG] [PDF]
V/MRP/05/1640-05 150 mg 120 Pilnšļirce, 1 deva [PDF]
Tramcoat 80 mg V/DCP/24/0014 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0014-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0014-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -

3082 records